Integrated Upper Gastrointestinal Response to Food Intake

Gastroenterology

Volumn 131, Issue 2, 2006, Pages 640-658

  Camilleri, Michael ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; APOLIPOPROTEIN A4; BICARBONATE; BILE ACID; CARBOHYDRATE; CHOLECYSTOKININ; GASTRIN; GHRELIN; GLUCAGON; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 4; GLUCOSE TRANSPORTER 5; LEPTIN; LIPID; NEUROPEPTIDE Y; PEPTIDE YY; PROTEIN; TRIACYLGLYCEROL LIPASE;

BILE ACID SYNTHESIS; BILE SECRETION; CARBOHYDRATE DIET; CENTRAL NERVOUS SYSTEM; DIGESTION; FAT INTAKE; FEEDING; FOOD INTAKE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT FUNCTION; HUMAN; INTESTINE FUNCTION; MACRONUTRIENT; MOTOR PERFORMANCE; PANCREAS FUNCTION; PANCREAS SECRETION; PRIORITY JOURNAL; PROTEIN INTAKE; REVIEW; SATIETY; STOMACH ABSORPTION; STOMACH ACID SECRETION; STOMACH EMPTYING; STOMACH FUNCTION; STOMACH PH; TASTE;

EID: 33746517597     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.03.023     Document Type: Review

References (213)

1. Katschinski M. Nutritional implications of cephalic phase gastrointestinal responses. Appetite 34 (2000) 189-196
2. Powley T.L. Vagal circuitry mediating cephalic-phase responses to food. Appetite 34 (2000) 184-188
3. Coulie B., and Camilleri M. Intestinal pseudo-obstruction. Annu Rev Med 50 (1999) 37-55
4. Thumshirn M., Camilleri M., Saslow S.B., Williams D.E., Burton D.D., and Hanson R.B. Gastric accommodation in nonulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut 44 (1999) 55-64
5. Kuiken S.D., Samsom M., Camilleri M., Mullan B.P., Burton D.D., Kost L.J., Hardyman T.J., and O'Connor M.K. Development of a test to measure gastric accommodation in humans. Am J Physiol 277 (1999) G1217-G1221
6. Bouras E.P., Delgado-Aros S., Camilleri M., Castillo E.J., Burton D.D., Thomforde G.M., and Chial H.J. SPECT imaging of the stomach. comparison with barostat and effects of sex, age, body mass index, and fundoplication. Gut 51 (2002) 781-786
7. Kellow J.E., Borody T.J., Phillips S.F., Tucker R.L., and Haddad A.C. Human interdigestive motility. variations in patterns from esophagus to colon. Gastroenterology 91 (1986) 386-395
8. Spiller R.C., Trotman I.F., Higgins B.E., Ghatei M.A., Grimble G.K., Lee Y.C., Bloom S.R., Misiewicz J.J., and Silk D.B. The ileal brake-inhibition of jejunal motility after ileal fat perfusion in man. Gut 25 (1984) 365-374
9. Read N.W., McFarlane A., Kinsman R.I., Bates T.E., Blackhall N.W., Farrar G.B., Hall J.C., Moss G., Morris A.P., O'Neill B., et al. Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon. Gastroenterology 86 (1984) 274-280
10. Clain J.E., Malagelada J.R., Go V.L., and Summerskill W.H. Participation of the jejunum and ileum in postprandial gastric secretion in man. Gastroenterology 73 (1977) 211-214
11. Jain N.K., Boivin M., Zinsmeister A.R., and DiMagno E.P. The ileum and carbohydrate-mediated feedback regulation of postprandial pancreaticobiliary secretion in normal humans. Pancreas 6 (1991) 495-505
12. Sarr M.G., Foley M.K., Winters R.C., Duenes J.A., and DiMagno E.P. Role of extrinsic innervation in carbohydrate-induced ileal modulation of pancreatic secretion and upper gut function. Pancreas 14 (1997) 166-173
13. Spiller R.C., Trotman I.F., Adrian T.E., Bloom S.R., Misiewicz J.J., and Silk D.B. Further characterisation of the 'ileal brake' reflex in man-effect of ileal infusion of partial digests of fat, protein, and starch on jejunal motility and release of neurotensin, enteroglucagon, and peptide YY. Gut 29 (1988) 1042-1051
14. Van Citters G.W., and Lin H.C. The ileal brake. a fifteen-year progress report. Curr Gastroenterol Rep 1 (1999) 404-409
15. Brown N.J., Rumsey R.D., Bogentoft C., and Read N.W. The effect of an opiate receptor antagonist on the ileal brake mechanism in the rat. Pharmacology 47 (1993) 230-236
16. Brown N.J., Horton A., Rumsey R.D., and Read N.W. Granisetron and ondansetron. effects on the ileal brake mechanism in the rat. J Pharm Pharmacol 45 (1993) 521-524
17. Brown N.J., Rumsey R.D., Bogentoft C., and Read N.W. The effect of adrenoceptor antagonists on the ileal brake mechanism in the rat. Br J Pharmacol 105 (1992) 751-755
18. Hinder R.A., and Kelly K.A. Canine gastric emptying of solids and liquids. Am J Physiol 233 (1977) E335-E340
19. Kelly K.A. Gastric emptying of liquids and solids. roles of proximal and distal stomach. Am J Physiol 239 (1980) G71-G76
20. Camilleri M., Malagelada J.-R., Brown M.L., Becker G., and Zinsmeister A.R. Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol 249 (1985) G580-G585
21. Azpiroz F., and Malagelada J.-R. Gastric tone measured by an electronic barostat in health and postsurgical gastroparesis. Gastroenterology 92 (1987) 934-943
22. Houghton L.A., Read N.W., Heddle R., Horowitz M., Collins P.J., Chatterton B., and Dent J. Relationship of the motor activity of the antrum, pylorus, and duodenum to gastric emptying of a solid-liquid mixed meal. Gastroenterology 94 (1988) 1285-1291
23. Elashoff J.D., Reedy T.J., and Meyer J.H. Analysis of gastric emptying data. Gastroenterology 83 (1982) 1306-1312
24. Collins P.J., Houghton L.A., Read N.W., Horowitz M., Chatterton B.E., Heddle R., and Dent J. Role of the proximal and distal stomach in mixed solid and liquid meal emptying. Gut 32 (1991) 615-619
25. MacGregor I.L., Martin P., and Meyer J.H. Gastric emptying of solid food in normal man and after subtotal gastrectomy and truncal vagotomy with pyloroplasty. Gastroenterology 72 (1977) 206-211
26. Meyer J.H., Ohashi H., Jehn D., and Thomson J.B. Size of liver particles emptied from the human stomach. Gastroenterology 80 (1981) 1489-1496
27. Siegel J.A., Urbain J.L., Adler L.P., Charkes N.D., Maurer A.H., Krevsky B., Knight L.C., Fisher R.S., and Malmud L.S. Biphasic nature of gastric emptying. Gut 29 (1988) 85-89
28. Burton D.D., Kim H.J., Camilleri M., Stephens D.A., Mullan B.P., O'Connor M.K., and Talley N.J. Relationship of gastric emptying and volume changes after a solid meal in humans. Am J Physiol 289 (2005) 261-266
29. Hunt J.N., and Pathiak J.D. The osmotic effects of some simple molecules and ions on gastric emptying. J Physiol (Lond) 154 (1960) 254-269
30. Hunt J.N. Mechanisms and disorders of gastric emptying. Annu Rev Med 34 (1983) 219-229
31. Glatzle J., Wang Y., Adelson D.W., Kalogeris T.J., Zittel T.T., Tso P., Wei J.Y., and Raybould H.E. Chylomicron components activate duodenal vagal afferents via a cholecystokinin A receptor-mediated pathway to inhibit gastric motor function in the rat. J Physiol 550 (2003) 657-664
32. Glatzle J., Kalogeris T.J., Zittel T.T., Guerrini S., Tso P., and Raybould H.E. Chylomicron components mediate intestinal lipid-induced inhibition of gastric motor function. Am J Physiol 282 (2002) G86-G91
33. Lal S., McLaughlin J., Barlow J., D'Amato M., Giacovelli G., Varro A., Dockray G.J., and Thompson D.G. Cholecystokinin pathways modulate sensations induced by gastric distension in humans. Am J Physiol 287 (2004) G72-G79
34. Feinle C., D'Amato M., and Read N.W. Cholecystokinin-A receptors modulate gastric sensory and motor responses to gastric distension and duodenal lipid. Gastroenterology 110 (1996) 1379-1385
35. Heddle R., Dent J., Read N.W., Houghton L.A., Toouli J., Horowitz M., Maddern G.J., and Downton J. Antropyloroduodenal motor responses to intraduodenal lipid infusion in healthy volunteers. Am J Physiol 254 (1988) G671-G679
36. Keinke O., and Ehrlein H.J. Effect of oleic acid on canine gastroduodenal motility, pyloric diameter and gastric emptying. Q J Exp Physiol 68 (1983) 675-686
37. Lin H.C., van Citters G.W., Heimer F., and Bonorris G. Slowing of gastrointestinal transit by oleic acid. a preliminary report of a novel, nutrient-based treatment in humans. Dig Dis Sci 46 (2001) 223-229
38. Castiglione K.E., Read N.W., and French S.J. Adaptation to high-fat diet accelerates emptying of fat but not carbohydrate test meals in humans. Am J Physiol 282 (2002) R366-R371
39. Covasa M., and Ritter R.C. Adaptation to high-fat diet reduces inhibition of gastric emptying by CCK and intestinal oleate. Am J Physiol 278 (2000) R166-R170
40. Camilleri M., Brown M.L., and Malagelada J.R. Impaired transit of chyme in chronic intestinal pseudoobstruction. Correction by cisapride. Gastroenterology 91 (1986) 619-626
41. Kerlin P., Zinsmeister A., and Phillips S.F. Relationship of motility to flow of contents in the human small intestine. Gastroenterology 82 (1982) 701-706
42. Greydanus M.P., Camilleri M., Colemont L.J., Phillips S.F., Brown M.L., and Thomforde G.M. Ileocolonic transfer of solid chyme in small intestinal neuropathies and myopathies. Gastroenterology 99 (1990) 158-164
43. Kerlin P., and Phillips S. Differential transit of liquids and solid residue through the human ileum. Am J Physiol 245 (1983) G38-G43
44. Quigley E.M., Borody T.J., Phillips S.F., Wienbeck M., Tucker R.L., and Haddad A. Motility of the terminal ileum and ileocecal sphincter in healthy humans. Gastroenterology 87 (1984) 857-866
45. Lin H.C., Zhao X.T., and Wang L. Intestinal transit is more potently inhibited by fat in the distal (ileal brake) than in the proximal (jejunal brake) gut. Dig Dis Sci 42 (1997) 19-25
46. Lin H.C., Zhao X.T., and Wang L. Fat absorption is not complete by midgut but is dependent on load of fat. Am J Physiol 271 (1996) G62-G67
47. Lin H.C., Zhao X.T., Wang L., and Wong H. Fat-induced ileal brake in the dog depends on peptide YY. Gastroenterology 110 (1996) 1491-1495
48. Lin H.C., Zhao X.T., and Wang L. Jejunal brake. inhibition of intestinal transit by fat in the proximal small intestine. Dig Dis Sci 41 (1996) 326-329
49. Schmidt W.E., and Bojko J.B. Regulation of gastric acid secretion. In: Greeley G.H. (Ed). Gastrointestinal endocrinology (1998), Humana, Totowa, NJ 353-391
50. Schubert M.L. Gastric secretion. Curr Opin Gastroenterol 19 (2003) 519-525
51. Schmidt W.E., and Schmitz F. Genetic dissection of the secretory machinery in the stomach. Gastroenterology 126 (2004) 606-609
52. Kovacs T.O., Walsh J.H., Maxwell V., Wong H.C., Azuma T., and Katt E. Gastrin is a major mediator of the gastric phase of acid secretion in dogs. proof by monoclonal antibody neutralization. Gastroenterology 97 (1989) 1406-1413
53. Crean G.P., Marshall M.W., and Rumsey R.D. Parietal cell hyperplasia induced by the administration of pentagastrin (ICI 50,123) to rats. Gastroenterology 57 (1969) 147-155
54. Grossman M.I. Regulation of gastric acid secretion. In: Johnson L.R. (Ed). Physiology of the gastrointestinal tract (1984), Raven, New York 659-672
55. Wank S.A. G protein-coupled receptors in gastrointestinal physiology. I. CCK receptors. an exemplary family. Am J Physiol 274 (1998) G607-G613
56. Chen D., Zhao C.M., Hakanson R., and Rehfeld J.F. Gastric phenotypic abnormality in cholecystokinin 2 receptor null mice. Pharmacol Toxicol 91 (2002) 375-381
57. Schmidt W.E., Schenk S., Nustede R., Holst J.J., Folsch U.R., and Creutzfeldt W. Cholecystokinin is a negative regulator of gastric acid secretion and postprandial release of gastrin in humans. Gastroenterology 107 (1994) 1610-1620
58. Chen D., Zhao C.M., Hakanson R., Samuelson L.C., Rehfeld J.F., and Friis-Hansen L. Altered control of gastric acid secretion in gastrin-cholecystokinin double mutant mice. Gastroenterology 126 (2004) 476-487
59. Theisen J., Nehra D., Citron D., Johansson J., Hagen J.A., Crookes P.F., DeMeester S.R., Bremner C.G., DeMeester T.R., and Peters J.H. Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. J Gastrointest Surg 4 (2000) 50-54
60. Ferreira A., Sue D., O'Byrne C.P., and Boor K.J. Role of Listeria monocytogenes sigma(B) in survival of lethal acidic conditions and in the acquired acid tolerance response. Appl Environ Microbiol 69 (2003) 2692-2698
61. Longstreth G.F., Go V.L.W., and Malagelada J.R. Postprandial gastric, pancreatic, and biliary response to histamine H2-receptor antagonists in active duodenal ulcer. Gastroenterology 72 (1977) 9-13
62. Erickson R.H., and Kim Y.S. Digestion and absorption of dietary protein. Annu Rev Med 41 (1990) 133-139
63. Carrière F., Barrowman J.A., Verger R., and Laugier R. Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans. Gastroenterology 105 (1993) 876-888
64. Wojdemann M., Olsen O., Norregaard P., Sternby B., and Rehfeld J.F. Gastric lipase secretion after sham feeding and cholinergic blockade. Dig Dis Sci 42 (1997) 1070-1075
65. Wojdemann M., Sternby B., Larsen S., and Olsen O. Cephalic phase of lipolysis is impaired in pancreatic insufficiency. role of gastric lipase. Scand J Gastroenterol 35 (2000) 204-211
66. Moreau J., Bouisson M., Balas D., Ravaud A., Stupnik S., Buscail L., Vaysse N., and Ribet A. Gastric lipase in alcoholic pancreatitis. comparison of secretive profiles following pentagastrin stimulation in normal adults and patients with pancreatic insufficiency. Gastroenterology 99 (1990) 175-180
67. Borovicka J., Schwizer W., Mettraux C., Kreiss C., Remy B., Asal K., Jansen J.B., Douchet I., Verger R., and Fried M. Regulation of gastric and pancreatic lipase secretion by CCK and cholinergic mechanisms in humans. Am J Physiol 273 (1997) G374-G380
68. Wojdemann M., Riber C., Bisgaard T., Sternby B., Larsen S., Rehfeld J.F., Holst J.J., and Olsen O. Inhibition of human gastric lipase by intraduodenal fat involves glucagon-like peptide-1 and cholecystokinin. Regul Pept 80 (1999) 101-106
69. Armand M., Borel P., Pasquier B., Dubois C., Senft M., Andre M., Peyrot J., Salducci J., and Lairon D. Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum. Am J Physiol 271 (1996) G172-G183
70. Guimbaud R., Moreau J.A., Bouisson M., Durand S., Escourrou J., Vaysse N., and Frexinos J. Intraduodenal free fatty acids rather than triglycerides are responsible for the release of CCK in humans. Pancreas 14 (1997) 76-82
71. Carriere F., Barrowman J.A., Verger R., and Laugier R. Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans. Gastroenterology 105 (1993) 876-888
72. Alpers D.H. Digestion and absorption of carbohydrates and proteins. In: Johnson L.R. (Ed). Physiology of the gastrointestinal tract (1994), Raven, New York 1723-1749
73. Dutta S.K. Vitamin B12 malabsorption and omeprazole therapy. J Am Coll Nutr 13 (1994) 544-545
74. Champagne E.T. Low gastric hydrochloric acid secretion and mineral bioavailability. Adv Exp Med Biol 249 (1989) 173-184
75. Konturek P.C., Konturek S.J., and Ochmanski W. Neuroendocrinology of gastric H+ and duodenal HCO3- secretion. the role of brain-gut axis. Eur J Pharmacol 499 (2004) 15-22
76. Shorrock C.J., and Rees W.D. Overview of gastroduodenal mucosal protection. Am J Med 84 (1988) 25-34
77. Allen A., and Flemstrom G. Gastroduodenal mucus bicarbonate barrier. protection against acid and pepsin. Am J Physiol 288 (2005) C1-C19
78. Schalm S.W., LaRusso N.F., Hofmann A.F., Hoffman N.E., van Berge-Henegouwen G.P., and Korman M.G. Diurnal serum levels of primary conjugated bile acids. Assessment by specific radioimmunoassays for conjugates of cholic and chenodeoxycholic acid. Gut 19 (1978) 1006-1014
79. Duane W.C., Levitt D.G., Mueller S.M., and Behrens J.C. Regulation of bile acid synthesis in man. Presence of a diurnal rhythm. J Clin Invest 72 (1983) 1930-1936
80. Galman C., Angelin B., and Rudling M. Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis. Gastroenterology 129 (2005) 1445-1453
81. Angelin B., Bjorkhem I., Einarsson K., and Ewerth S. Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum. J Clin Invest 70 (1982) 724-731
82. Hofmann A.F. The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med 159 (1999) 2647-2658
83. Russell D.W., and Setchell K.D. Bile acid biosynthesis. Biochemistry 31 (1992) 4737-4749
84. Fuchs M. Bile acid regulation of hepatic physiology: III. Regulation of bile acid synthesis: past progress and future challenges. Am J Physiol 284 (2003) G551-G557
85. Kullak-Ublick G.A., Stieger B., and Meier P.J. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 126 (2004) 322-342
86. Layer P., Chan A.T., Go V.L., and DiMagno E.P. Human pancreatic secretion during phase II antral motility of the interdigestive cycle. Am J Physiol 254 (1988) G249-G253
87. Romanski K.W., Peeters T.L., Bormans V., Vantrappen G.R., and Janssens J. Interdigestive fluctuations of plasma bile acid concentration. relation to interdigestive motility pattern. Hepatogastroenterology 34 (1987) 24-27
88. Green G.M. Feedback inhibition of cholecystokinin secretion by bile acids and pancreatic proteases. Ann N Y Acad Sci 713 (1994) 167-179
89. Carey M.C., and Small D.M. Micelle formation by bile salts. Physical-chemical and thermodynamic considerations. Arch Intern Med 130 (1972) 506-527
90. Nordskog B.K., Phan C.T., Nutting D.F., and Tso P. An examination of the factors affecting intestinal lymphatic transport of dietary lipids. Adv Drug Deliv Rev 50 (2001) 21-44
91. Wong M.H., Oelkers P., Craddock A.L., and Dawson P.A. Expression cloning and characterization of the hamster ileal sodium-dependent bile acid transporter. J Biol Chem 269 (1994) 1340-1347
92. Layer P., Zinsmeister A.R., and DiMagno E.P. Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans. Gastroenterology 91 (1986) 41-48
93. DiMagno E.P., and Layer P. Human exocrine pancreatic enzyme secretion. In: Go V.L. (Ed). The pancreas. biology, pathobiology and diseases. 2nd ed. (1993), Raven, New York 275-300
94. DiMagno E.P., Clain J.E., and Layer P. Chronic pancreatitis. In: Go V.L. (Ed). The pancreas. biology, pathobiology and diseases. 2nd ed. (1993), Raven, New York 665-706
95. Hofmann A.F., and Borgström B. The intraluminal phase of fat digestion in man. the lipid content of the micellar and oil phases of intestinal content obtained during fat digestion and absorption. J Clin Invest 43 (1964) 247-257
96. Borgstrom B., and Hildebrand H. Lipase and co-lipase activities of human small intestinal contents after a liquid test meal. Scand J Gastroenterol 10 (1975) 585-591
97. Lowe M.E. The triglyceride lipases of the pancreas. J Lipid Res 43 (2002) 2007-2016
98. Keller J., Holst J.J., and Layer P. Inhibition of human pancreatic and biliary output but not intestinal motility by physiological intra-ileal lipid loads. Am J Physiol Gastrointest Liver Physiol 290 (2006) G704-G709
99. Borgstrom D Dahlquist A., Lundh G., and Sjovall G. Studies of intestinal digestion and absorption in the human. J Clin Invest 36 (1957) 1521-1536
100. Johansson C. Studies of gastrointestinal interactions. VII. Characteristics of the absorption pattern of sugar, fat and protein from composite meals in man. A quantitative study. Scand J Gastroenterol 10 (1975) 33-42
101. McMichael H.B., Webb J., and Dawson A.M. The absorption of maltose and lactose in man. Clin Sci 33 (1967) 135-145
102. Maroux S., Louvard D., Vannier C., and Semeriva M. Structure-function relationship of intestinal and renal brush-border membrane-bound aminopeptidases and maltases. Biochem Soc Trans 5 (1977) 523-527
103. Holdsworth C.D., and Dawson A.M. The absorption of monosaccharides in man. Clin Sci 27 (1964) 371-379
104. McMichael H.B. A second intestinal glucose carrier. Gut 14 (1973) 428-429
105. Bieberdorf F.A., Morawski S., and Fordtran J.S. Effect of sodium, mannitol, and magnesium on glucose, galactose, 3-O-methylglucose, and fructose absorption in the human ileum. Gastroenterology 68 (1975) 58-66
106. Thorens B. Glucose transporters in the regulation of intestinal, renal, and liver glucose fluxes. Am J Physiol 270 (1996) G541-G553
107. Adibi S.A., and Mercer D.W. Protein digestion in human intestine as reflected in luminal, mucosal, and plasma amino acid concentrations after meals. J Clin Invest 52 (1973) 1586-1594
108. Donlon J., and Fottrell P.F. Studies on substrate specificities and subcellular location of multiple forms of peptide hydrolases in guinea-pig intestinal mucosa. Comp Biochem Physiol [B] 41 (1972) 181-193
109. Addison J.M., Burston D., and Matthews D.M. Evidence for active transport of the dipeptide glycylsarcosine by hamster jejunum in vitro. Clin Sci 43 (1972) 907-911
110. Ganapathy, and Leibach F.H. Is intestinal peptide transport energized by a proton gradient?. Am J Physiol 249 (1985) G153-G160
111. Groneberg D.A., Doring F., Eynott P.R., Fischer A., and Daniel H. Intestinal peptide transport. ex vivo uptake studies and localization of peptide carrier PEPT1. Am J Physiol 281 (2001) G697-G704
112. Kleta R., Romeo E., Ristic Z., Ohura T., Stuart C., Arcos-Burgos M., Dave M.H., Wagner C.A., Camargo S.R., Inoue S., Matsuura N., Helip-Wooley A., Bockenhauer D., Warth R., Bernardini I., Visser G., Eggermann T., Lee P., Chairoungdua A., Jutabha P., Babu E., Nilwarangkoon S., Anzai N., Kanai Y., Verrey F., Gahl W.A., and Koizumi A. Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder. Nat Genet 36 (2004) 999-1002
113. Asatoor A.M., Crouchman M.R., Harrison A.R., Light F.W., Loughridge L.W., Milne M.D., and Richards A.J. Intestinal absorption of oligopeptides in cystinuria. Clin Sci 41 (1971) 23-33
114. Condon J.R., and Asatoor A.M. Amino acid metabolism in uraemic patients. Clin Chim Acta 32 (1971) 333-337
115. Asatoor A.M., Cheng B., Edwards K.D., Lant A.F., Matthews D.M., Milne M.D., Navab F., and Richards A.J. Intestinal absorption of two dipeptides in Hartnup disease. Gut 11 (1970) 380-387
116. Fairclough P.D., Silk D.B., Clark M.L., Matthews D.M., Marrs T.C., Burston D., and Clegg K.M. Effect of glycylglycine on absorption from human jejunum of an amino acid mixture simulating casein and a partial enzymic hydrolysate of casein containing small peptides. Clin Sci Mol Med 53 (1977) 27-33
117. Silk D.B., and Dawson A.M. Intestinal absorption of carbohydrate and protein in man. Int Rev Physiol 19 (1979) 51-204
118. Adibi S.A., Fogel M.R., and Agrawal R.M. Comparison of free amino acid and dipeptide absorption in the jejunum of sprue patients. Gastroenterology 67 (1974) 586-591
119. Silk D.B., Kumar P.J., Perrett D., Clark M.L., and Dawson A.M. Amino acid and peptide absorption in patients with coeliac disease and dermatitis herpetiformis. Gut 15 (1974) 1-8
120. Thomson A.B., Schoeller C., Keelan M., Smith L., and Clandinin M.T. Lipid absorption. passing through the unstirred layers, brush-border membrane, and beyond. Can J Physiol Pharmacol 71 (1993) 531-555
121. Tso P., and Balint J.A. Formation and transport of chylomicrons by enterocytes to the lymphatics. Am J Physiol 250 (1986) G715-G726
122. Kirkup A.J., Brunsden A.M., and Grundy D. Receptors and transmission in the brain-gut axis: potential for novel therapies. I. Receptors on visceral afferents. Am J Physiol 280 (2001) G787-G794
123. Strader A.D., and Woods S.C. Gastrointestinal hormones and food intake. Gastroenterology 128 (2005) 175-191
124. Dockray G., Dimaline R., and Varro A. Gastrin. old hormone, new functions. Pflugers Arch 449 (2005) 344-355
125. Dockray G.J., Varro A., Dimaline R., and Wang T. The gastrins. their production and biological activities. Annu Rev Physiol 63 (2001) 119-139
126. Kinoshita Y., Ishihara S., Kadowaki Y., Fukui H., and Chiba T. Reg protein is a unique growth factor of gastric mucosal cells. J Gastroenterol 39 (2004) 507-513
127. Raybould H.E., and Lloyd K.C. Integration of postprandial function in the proximal gastrointestinal tract. Role of CCK and sensory pathways. Ann N Y Acad Sci 713 (1994) 143-156
128. Lal S., McLaughlin J., Barlow J., D'Amato M., Giacovelli G., Varro A., Dockray G.J., and Thompson D.G. Cholecystokinin pathways modulate sensations induced by gastric distension in humans. Am J Physiol 287 (2004) G72-G79
129. Moran T.H., Ladenheim E.E., and Schwartz G.J. Within-meal gut feedback signaling. Int J Obes Relat Metab Disord 25 Suppl 5 (2001) S39-S41
130. Beglinger C., and Degen L. Fat in the intestine as a regulator of appetite-role of CCK. Physiol Behav 83 (2004) 617-621
131. Feinle C., D'Amato M., and Read N.W. Cholecystokinin-A receptors modulate gastric sensory and motor responses to gastric distension and duodenal lipid. Gastroenterology 110 (1996) 1379-1385
132. Schick R.R., Yaksh T.L., Roddy D.R., and Go V.L. Release of hypothalamic cholecystokinin in cats. effects of nutrient and volume loading. Am J Physiol 256 (1989) R248-R254
133. Burdakov D., and Ashcroft F.M. Cholecystokinin tunes firing of an electrically distinct subset of arcuate nucleus neurons by activating A-type potassium channels. J Neurosci 22 (2002) 6380-6387
134. Kobelt P., Tebbe J.J., Tjandra I., Stengel A., Bae H.G., Andresen V., van der Voort I.R., Veh R.W., Werner C.R., Klapp B.F., Wiedenmann B., Wang L., Tache Y., and Monnikes H. CCK inhibits the orexigenic effect of peripheral ghrelin. Am J Physiol 288 (2005) R751-R758
135. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
136. Kojima M., and Kangawa K. Ghrelin. structure and function. Physiol Rev 85 (2005) 495-522
137. Dass N.B., Munonyara M., Bassil A.K., Hervieu G.J., Osbourne S., Corcoran S., Morgan M., and Sanger G.J. Growth hormone secretagogue receptors in rat and human gastrointestinal tract and the effects of ghrelin. Neuroscience 120 (2003) 443-453
138. Korner J., and Leibel R.L. To eat or not to eat-how the gut talks to the brain. N Engl J Med 349 (2003) 926-928
139. Tschö P.M., Smiley D.L., and Heiman M.L. Ghrelin induces adiposity in rodents. Nature 407 (2000) 908-913
140. Cowley M.A., Smith R.G., Diano S., Tschop M., Pronchuk N., Grove K.L., Strasburger C.J., Bidlingmaier M., Esterman M., Heiman M.L., Garcia-Segura L.M., Nillni E.A., Mendez P., Low M.J., Sotonyi P., Friedman J.M., Liu H., Pinto S., Colmers W.F., Cone R.D., and Horvath T.L. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37 (2003) 649-661
141. Toshinai K., Date Y., Murakami N., Shimada M., Mondal M.S., Shimbara T., Guan J.L., Wang Q.P., Funahashi H., Sakurai T., Shioda S., Matsukura S., Kangawa K., and Nakazato M. Ghrelin-induced food intake is mediated via the orexin pathway. Endocrinology 144 (2003) 1506-1512
142. Date Y., Murakami N., Toshinai K., Matsukura S., Niijima A., Matsuo H., Kangawa K., and Nakazato M. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123 (2002) 1120-1128
143. Ueno H., Yamaguchi H., Kangawa K., and Nakazato M. Ghrelin. a gastric peptide that regulates food intake and energy homeostasis. Regul Pept 126 (2005) 11-19
144. Jarkovska Z., Krsek M., Rosicka M., and Marek J. Endocrine and metabolic activities of a recently isolated peptide hormone ghrelin, an endogenous ligand of the growth hormone secretagogue receptor. Endocr Regul 38 (2004) 80-86
145. Korbonits M., and Grossman A.B. Ghrelin. update on a novel hormonal system. Eur J Endocrinol 151 (2005) S67-S70
146. Sun Y., Ahmed S., and Smith R.G. Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 23 (2003) 7973-7981
147. Sun Y., Wang P., Zheng H., and Smith R.G. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci U S A 101 (2004) 4679-4684
148. Murray C.D., Martin N.M., Patterson M., Taylor S.A., Ghatei M.A., Kamm M.A., Johnston C., Bloom S.R., and Emmanuel A.V. Ghrelin enhances gastric emptying in diabetic gastroparesis. a double-blind, placebo-controlled, crossover study. Gut 54 (2005) 1693-1698
149. Tack J., DePoortere I., Bisschops R., Verbeke K., Janssens J., and Peeters T. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment Pharmacol Ther 22 (2005) 847-853
150. Cremonini F., Camilleri M., Vazquez Roque M., McKinzie S., Burton D., Baxter K., and Zinsmeister A.R. Effect of synthetic human ghrelin on gastric motor function and postprandial symptoms in normal weight and obesity. randomized, double-blind, placebo-controlled study. Neurogastroenterol Motil 17 (2005) 631-632
151. Zhang J.V., Ren P.G., Avsian-Kretchmer O., Luo C.W., Rauch R., Klein C., and Hsueh A.J. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310 (2005) 996-999
152. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., and Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994) 425-432
153. Masuzaki H., Ogawa Y., Sagawa N., Hosoda K., Matsumoto T., Mise H., Nishimura H., Yoshimasa Y., Tanaka I., Mori T., and Nakao K. Nonadipose tissue production of leptin (leptin as a novel placenta-derived hormone in humans). Nat Med 3 (1997) 1029-1033
154. Wang J., Liu R., Hawkins M., Barzilai N., and Rossetti L. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature 393 (1998) 684-688
155. Bado A., Levasseur S., Attoub S., Kermorgant S., Laigneau J.P., Bortoluzzi M.N., Moizo L., Lehy T., Guerre-Millo M., Le Marchand-Brustel Y., and Lewin M.J. The stomach is a source of leptin. Science 394 (1998) 90-93
156. Cinti S., Matteis R.D., Pico C., Ceresi E., Obrador A., Maffeis C., Oliver J., and Palou A. Secretory granules of endocrine and chief cells of human stomach mucosa contain leptin. Int J Obes Relat Metab Disord 24 (2000) 789-793
157. Sobhani I., Bado A., Vissuzaine C., Buyse M., Kermorgant S., Laigneau J.P., Attoub S., Lehy T., Henin D., Mignon M., and Lewin M.J. Leptin secretion and leptin receptor in the human stomach. Gut 47 (2000) 178-183
158. Pico C., Sanchez J., Oliver P., and Palou A. Leptin production by the stomach is up-regulated in obese (fa/fa) Zucker rats. Obes Res 10 (2002) 932-938
159. Goiot H., Laigneau J.P., Devaud H., Sobhani I., and Bado A. Similarities and differences in the transcriptional regulation of the leptin gene promoter in gastric and adipose cells. FEBS Lett 579 (2005) 1911-1916
160. Ahima R.S., Prabakaran D., Mantzoros C., Qu D., Lowell B., Maratos-Flier E., and Flier J.S. Role of leptin in the neuroendocrine response to fasting. Nature 382 (1996) 250-252
161. Elmquist J.K., Elias C.F., and Saper C.B. From lesions to leptin (hypothalamic control of food intake and body weight). Neuron 22 (1999) 221-232
162. Pico C., Oliver P., Sanchez J., and Palou A. Gastric leptin. a putative role in the short-term regulation of food intake. Br J Nutr 90 (2003) 735-741
163. Kalra S.P., and Kalra P.S. Neuropeptide Y. a physiological orexigen modulated by the feedback action of ghrelin and leptin. Endocrine 22 (2003) 49-56
164. Ishiguchi T., Amano T., Matsubayashi H., Tada H., Fujita M., and Takahashi T. Centrally administered neuropeptide Y delays gastric emptying via Y2 receptors in rats. Am J Physiol 281 (2001) R1522-R1530
165. Allen J.M., Fitzpatrick M.L., Yeats J.C., Darcy K., Adrian T.E., and Bloom S.R. Effects of peptide YY and neuropeptide Y on gastric emptying in man. Digestion 30 (1984) 255-262
166. Bell G.I., Santerre R.F., and Mullenbach G.T. Hamster preproglucagon contains the sequence of glucagon and two related peptides. Nature 302 (1983) 716-718
167. Holst J.J. Enteroglucagon. Annu Rev Physiol 59 (1997) 257-272
168. Drucker D.J., Erlich P., Asa S.L., and Brubaker P.L. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci U S A 93 (1996) 7911-7916
169. Kolligs F., Fehmann H.C., Göke R., and Göke B. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide. Diabetes 44 (1995) 16-19
170. Wang Z., Wang R.M., Owji A.A., Smith D.M., Ghatei M., and Bloom S.R. Glucagon-like peptide-1 is a physiological incretin in rat. J Clin Invest 95 (1995) 417-421
171. Scrocchi L., Brown T.J., MacLusky N., Brubaker P.L., Auerbach A.B., Joyner A.L., and Drucker D.J. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med 2 (1996) 1254-1258
172. Flint A., Raben A., Astrup A., and Holst J.J. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 101 (1998) 515-520
173. Schirra J., Wank U., Arnold R., Goke B., and Katschinski M. Effects of glucagon-like peptide-1(7-36)amide on motility and sensation of the proximal stomach in humans. Gut 50 (2002) 341-348
174. Delgado-Aros S., Vella A., Camilleri M., Low P.A., Burton D.D., Thomforde G.M., and Stephens D. Effects of glucagon-like peptide-1 and feeding on gastric volumes in diabetes mellitus with cardio-vagal dysfunction. Neurogastroenterol Motil 15 (2003) 435-443
175. Delgado-Aros S., Kim D.Y., Burton D.D., Thomforde G.M., Stephens D., Brinkmann B.H., Vella A., and Camilleri M. Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans. Am J Physiol 282 (2002) G424-G431
176. Vella A., Shah P., Basu R., Basu A., Camilleri M., Schwenk F.W., Holst J.J., and Rizza R.A. Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes. Diabetes 50 (2001) 565-572
177. Schirra J., Nicolaus M., Roggel R., Katschinski M., Storr M., Woerle H.J., and Goke B. Endogenous GLP-1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans. Gut 55 (2006) 243-251
178. Heine R.J., Van Gaal L.F., Johns D., Mihm M.J., Widel M.H., Brodows R.G., and GWAA Study Group. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes. a randomized trial. Ann Intern Med 143 (2005) 559-569
179. Layer P., and Holst J.J. GLP-1. a humoral mediator of the ileal brake in humans?. Digestion 54 (1993) 385-386
180. Read N., French S., and Cunningham K. The role of the gut in regulating food intake in man. Nutr Rev 52 (1994) 1-10
181. Wettergren A., Schjoldager B., Mortensen P.E., Myhre J., Christiansen J., and Holst J.J. Truncated GLP-1 (proglucagon 72-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 38 (1993) 665-673
182. Samsom M., Szarka L.A., Camilleri M., Vella A., Zinsmeister A.R., and Rizza R.A. Pramlintide, an amylin analog, selectively delays gastric emptying. potential role of vagal inhibition. Am J Physiol 278 (2000) G946-G951
183. Vella A., Lee J.S., Camilleri M., Szarka L.A., Burton D.D., Zinsmeister A.R., Rizza R.A., and Klein P.D. Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus. Neurogastroenterol Motil 14 (2002) 123-131
184. Lutz T.A. Pancreatic amylin as a centrally acting satiating hormone. Curr Drug Targets 6 (2005) 181-189
185. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L., Wren A.M., Brynes A.E., Low M.J., Ghatei M.A., Cone R.D., and Bloom S.R. Gut hormone PYY3-36 physiologically inhibits food intake. Nature 418 (2002) 650-654
186. Batterham R.L., Cohen M.A., Ellis S.M., Le Roux C.W., Withers D.J., Frost G.S., Ghatei M.A., and Bloom S.R. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349 (2003) 941-948
187. Degen L., Oesch S., Casanova M., Graf S., Ketterer S., Drewe J., and Beglinger C. Effect of peptide YY3-36 on food intake in humans. Gastroenterology 129 (2005) 1430-1436
188. Renshaw D., and Batterham R.L. Peptide YY. a potential therapy for obesity. Curr Drug Targets 6 (2005) 171-179
189. Pironi L., Stanghellini V., Miglioli M., Corinaldesi R., De Giorgio R., Ruggeri E., Tosetti C., Poggioli G., Morselli Labate A.M., Monetti N., et al. Fat-induced ileal brake in humans. a dose-dependent phenomenon correlated to the plasma levels of peptide YY. Gastroenterology 105 (1993) 733-739
190. Wen J., Phillips S.F., Sarr M.G., Kost L.J., and Holst J.J. PYY and GLP-1 contribute to feedback inhibition from the canine ileum and colon. Am J Physiol 269 (1995) G945-G952
191. Chen C.H., and Rogers R.C. Central inhibitory action of peptide YY on gastric motility in rats. Am J Physiol 269 (1995) R787-R792
192. Wen J., Luque-de Leon E., Kost L.J., Sarr M.G., and Phillips S.F. Duodenal motility in fasting dogs. humoral and neural pathways mediating the colonic brake. Am J Physiol 274 (1998) G192-G195
193. Chen C.H., Stephens Jr. R.L., and Rogers R.C. PYY and NPY. control of gastric motility via action on Y1 and Y2 receptors in the DVC. Neurogastroenterol Motil 9 (1997) 109-116
194. Cuche G., Cuber J.C., and Malbert C.H. Ileal short-chain fatty acids inhibit gastric motility by a humoral pathway. Am J Physiol 279 (2000) G925-G930
195. Fujimoto K., Cardelli J.A., and Tso P. Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiation. Am J Physiol 262 (1992) G1002-G1006
196. Tso P., and Balint J.A. Formation and transport of chylomicrons by enterocytes to the lymphatics. Am J Physiol 250 (1986) G715-G726
197. Hayashi H., Fujimoto K., Cardelli J.A., Nutting D.F., Bergstedt S., and Tso P. Fat feeding increases size, but not number, of chylomicrons produced by small intestine. Am J Physiol 259 (1990) G709-G719
198. Kalogeris T.J., Tsuchiya T., Fukagawa K., Wolf R., and Tso P. Apolipoprotein A-IV synthesis in proximal jejunum is stimulated by ileal lipid infusion. Am J Physiol 270 (1996) G277-G286
199. Fujimoto K., Fukagawa K., Sakata T., and Tso P. Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J Clin Invest 91 (1993) 1830-1833
200. Okumura T., Fukagawa K., Tso P., Taylor I.L., and Pappas T.N. Mechanism of action of intracisternal apolipoprotein A-IV in inhibiting gastric acid secretion in rats. Gastroenterology 109 (1995) 1583-1588
201. Okumura T., Fukagawa K., Tso P., Taylor I.L., and Pappas T.N. Apolipoprotein A-IV acts in the brain to inhibit gastric emptying in the rat. Am J Physiol 270 (1996) G49-G53
202. Glatzle J., Darcel N., Rechs A.J., Kalogeris T.J., Tso P., and Raybould H.E. Apolipoprotein A-IV stimulates duodenal vagal afferent activity to inhibit gastric motility via a CCK1 pathway. Am J Physiol 287 (2004) R354-R359
203. Whited K., Lu D., Tso P., Lloyd K., and Raybould H.E. Apolipoprotein A-IV is involved in detection of lipid in the intestine. J Physiol 569 (2005) 949-958
204. Geliebter A., Yahav E.K., Gluck M.E., and Hashim S.A. Gastric capacity, test meal intake, and appetitive hormones in binge eating disorder. Physiol Behav 81 (2004) 735-740
205. Delgado-Aros S., Camilleri M., Castillo E.J., Cremonini F., Stephens D., Ferber I., Baxter K., Burton D., and Zinsmeister A.R. Effect of gastric volume or emptying on meal-related symptoms after liquid nutrients in obesity. a pharmacologic study. Clin Gastroenterol Hepatol 3 (2005) 997-1006
206. Spannagel A.W., Nakano I., Tawil T., Chey W.Y., Liddle R.A., and Green G.M. Adaptation to fat markedly increases pancreatic secretory response to intraduodenal fat in rats. Am J Physiol 270 (1996) G128-G135
207. Boivin M., Lanspa S.J., Zinsmeister A.R., Go V.L., and DiMagno E.P. Are diets associated with different rates of human interdigestive and postprandial pancreatic enzyme secretion?. Gastroenterology 99 (1990) 1763-1771
208. Cunningham K.M., Daly J., Horowitz M., and Read N.W. Gastrointestinal adaptation to diets of differing fat composition in human volunteers. Gut 32 (1991) 483-486
209. Park M.I., Camilleri M., O'Connor H., Oenning L., Burton D., Stephens D., and Zinsmeister A.R. Effect of supplementing different macronutrients on gastric sensory and motor functions and appetite in normal weight, overweight or obese humans. Gastroenterology 130 (2006) A606
210. Boyd K.A., O'Donovan D.G., Doran S., Wishart J., Chapman I.M., Horowitz M., and Feinle C. High-fat diet effects on gut motility, hormone, and appetite responses to duodenal lipid in healthy men. Am J Physiol 284 (2003) G188-G196
211. French S.J., Murray B., Rumsey R.D., Fadzlin R., and Read N.W. Adaptation to high-fat diets. effects on eating behaviour and plasma cholecystokinin. Br J Nutr 73 (1995) 179-189
212. Oesch S., Degen L., and Beglinger C. Effect of a protein preload on food intake and satiety feelings in response to duodenal fat perfusions in healthy male subjects. Am J Physiol 289 (2005) R1042-R1047
213. Tome D. Protein, amino acids and the control of food intake. Br J Nutr 92 Suppl 1 (2004) S27-S30